课题基金 / 基金详情

Immune:microbiota cross-talk in regulation and repair of intestinal inflammation

Immune:microbiota cross-talk in regulation and repair of intestinal inflammation
免疫:微生物群串扰调节和修复肠道炎症
批准号:
MR/W018748/1
负责人:
Andrew MacDonald
金额:
$116.77万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2022
资助国家:
英国
项目状态:
未结题
起止时间:
2022 至 --

项目摘要

项目成果

Andrew MacDonald的其他基金

相似基金

相关文献

中文摘要
翻译
免疫系统是维持我们身体和环境之间屏障的核心,肠道在这方面面临着特殊的挑战,因为它们经常接触微生物、食物,甚至感染。然而,肠道细胞类型及其维持免疫健康、防止感染和限制过度炎症造成的损害的核心机制尚不完全清楚。由于肠道炎症性疾病可能是严重和危及生命的,因此迫切需要更好地了解这些过程的机制。炎症性肠病(包括溃疡性结肠炎和克罗恩病)提供了一个显著的例子,说明了调节屏障部位免疫的重要性,以及当这种免疫不平衡时会发生什么。这些慢性、复发性疾病伴随着巨大的痛苦,据估计,在英国,每250人中就有1人受到影响。因此,更好地了解调节屏障部位炎症的过程对于未来开发新疗法以预防影响全球数百万人的各种疾病至关重要。哺乳动物的肠道含有数万亿的“共生”或常驻微生物,微生物组成的改变直接与各种慢性炎症有关,包括炎症性肠病的出现、寿命和严重程度。然而,对肠道疾病期间这些微生物如何影响免疫、炎症和组织修复的理解仍然非常有限。寄生在肠道内的寄生虫在通过组织迁移和破裂时经常造成严重的损害。因此,这些寄生虫已经进化出有效的策略来确保“受调节的”肠道炎症,促进受损组织的快速有效修复,同时防止肠道内容物危险地扩散到底层组织和循环中。这些特性使寄生虫感染成为揭示肠道炎症和组织损伤调控重要机制的理想实验系统。本项目旨在利用小鼠寄生虫感染的实验系统,极大地增加我们对宿主免疫细胞和常驻微生物之间的串扰的理解,以及这种对话在控制肠道炎症和损伤中的重要性。更具体地说,我们的目标是发现控制这种相互作用的新机制,定义“调节”肠道炎症和组织修复的关键特征,这些特征可能是未来开发针对多种疾病的新疗法的候选者。
英文摘要
The immune system is central to maintaining the barrier between our bodies and the environment, with the intestines presenting a particular challenge in this regard given their constant exposure to microbes, food, and even infections. However, the intestinal cell types and the core mechanisms they employ to maintain immune health while protecting against infection and limiting damage caused by excessive inflammation are not completely understood. As inflammatory diseases of the intestine can be severe and life-threatening, better mechanistic understanding of these processes is urgently required. Inflammatory bowel diseases (including ulcerative colitis and Crohn's disease) provide a striking example of the importance of regulated barrier site immunity, and what can happen when this becomes unbalanced. These chronic, relapsing conditions are accompanied by significant suffering, with an estimated 1 in 250 people affected in the UK. Thus, better understanding of the processes that regulate inflammation at barrier sites is vital to enable future development of novel therapies to prevent a wide range of diseases that affect millions of people worldwide.Mammalian intestines contain trillions of 'commensal' or resident microbes, and alterations in microbial composition have been directly implicated in a variety of chronic inflammatory conditions, including emergence, longevity and severity of inflammatory bowel diseases. However, understanding of how these microbes influence immunity, inflammation and tissue repair during intestinal disease is still extremely limited.Parasitic worms that live in the intestines often cause significant damage as they migrate and rupture through tissues. Consequently, such parasites have evolved potent strategies to ensure 'regulated' intestinal inflammation, promoting rapid and effective repair of damaged tissues, while preventing the dangerous spread of gut contents into the underlying tissues and circulation. These attributes make parasitic worm infections ideal experimental systems to uncover vital mechanisms responsible for regulation of intestinal inflammation and tissue damage.This project aims to use an experimental system of parasitic worm infection in mice to dramatically increase our understanding of cross-talk between host immune cells and resident microbes, and the importance of this dialogue in controlling intestinal inflammation and damage. More specifically, we aim to discover novel mechanisms governing this interplay, to define key features of 'regulated' intestinal inflammation and tissue repair that could be candidates for future development of new therapies against a wide range of diseases.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
DOI: 10.3389/fimmu.2022.906338
发表时间: 2022
期刊: Frontiers in immunology
影响因子: 7.3
作者: []
通讯作者:
DOI: 10.1038/s41467-023-37502-z
发表时间: 2023-04-03
期刊: NATURE COMMUNICATIONS
影响因子: 16.6
作者: [Houlder, E. L., Costain, A. H., Nambuya, I., Brown, S. L., Koopman, J. P. R., Langenberg, M. C. C., Janse, J. J., Hoogerwerf, M. A., Ridley, A. J. L., Forde-Thomas, J. E., Colombo, S. A. P., Winkel, B. M. F., Galdon, A. A., Hoffmann, K. F., Cook, P. C., Roestenberg, M., Mpairwe, H., MacDonald, A. S.]
通讯作者: MacDonald, A. S.
DOI: 10.1093/discim/kyad009
发表时间: 2023
期刊: Discovery immunology
影响因子: --
作者: []
通讯作者:
DOI: 10.1038/s41385-021-00480-w
发表时间: 2022-03
期刊: Mucosal immunology
影响因子: 8
作者: [Bain CC, MacDonald AS]
通讯作者: MacDonald AS
共 6 条
    EAGER: Collaborative Research: Rapid Production of Geospatial Network Inputs for Spatially Explicit Epidemiological Modeling of COVID-19 in the USA
    NSF Postdoctoral Fellowship in Biology FY 2016
    • 批准号:
      1611767
    • 项目类别:
      Fellowship Award
    • 资助金额:
      $13.8万
    • 财政年份:
      2016
    • 负责人:
      Andrew MacDonald
    • 依托单位:
    Orchestration of the Th2 response by dendritic cells
    • 批准号:
      G0701437/1
    • 项目类别:
      Fellowship
    • 资助金额:
      $263.73万
    • 财政年份:
      2008
    • 负责人:
      Andrew MacDonald
    • 依托单位:
    国内基金
    海外基金
    肠道菌群介导的脱氧胆酸激活S1PR2/NLRP3/IL-1β通路在炎症性肠病合并艰难梭菌感染中的致病机制研究
    • 批准号:
      82372306
    • 项目类别:
      面上项目
    • 资助金额:
      48.00万元
    • 批准年份:
      2023
    • 负责人:
      彭奕冰
    • 依托单位:
    噬菌体靶向肠道粪肠球菌提高帕金森病左旋多巴疗效的机制研究
    • 批准号:
      82371251
    • 项目类别:
      面上项目
    • 资助金额:
      49.00万元
    • 批准年份:
      2023
    • 负责人:
      肖勤
    • 依托单位:
    西方饮食通过“肠道菌群-Rspo1”轴促进肥胖与肠道吸收的机制研究
    • 批准号:
      82370845
    • 项目类别:
      面上项目
    • 资助金额:
      48.00万元
    • 批准年份:
      2023
    • 负责人:
      洪洁
    • 依托单位:
    眼表菌群影响糖尿病患者干眼发生的人群流行病学研究
    • 批准号:
      82371110
    • 项目类别:
      面上项目
    • 资助金额:
      49.00万元
    • 批准年份:
      2023
    • 负责人:
      邹海东
    • 依托单位: